Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics

Cell Biol Toxicol. 2022 Oct;38(5):699-723. doi: 10.1007/s10565-021-09676-z. Epub 2021 Nov 5.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by progressive loss of pulmonary function. Drug-induced interstitial lung disease has been reported as a severe adverse effect of some drugs, such as bleomycin, amiodarone, and methotrexate. Based on good characteristics, drug-induced pulmonary fibrosis (PF) animal model has played a key role in our understanding of the molecular mechanisms of PF pathogenesis and recapitulates the specific pathology in patients and helps develop therapeutic strategies. Here, we summarize the mechanisms and characteristics of given fibrotic drug-induced animal models for PFs. Together with the key publications describing these models, this brief but detailed overview would be helpful for the pharmacological research with animal models of PFs. Potential mechanisms underlying drug induced lung toxicity.

Keywords: Amiodarone; Animal model; Bleomycin; Methotrexate; Pulmonary fibrosis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiodarone* / adverse effects
  • Animals
  • Bleomycin / toxicity
  • Disease Models, Animal
  • Idiopathic Pulmonary Fibrosis* / chemically induced
  • Lung / pathology
  • Lung Diseases, Interstitial* / chemically induced
  • Lung Diseases, Interstitial* / complications
  • Methotrexate / toxicity

Substances

  • Bleomycin
  • Amiodarone
  • Methotrexate